US2012058078A1PendingUtilityA1
Assay for the detection of factors that modulate the expression of ingap
Est. expiryJan 11, 2022(expired)· nominal 20-yr term from priority
A61P 3/10A61P 3/08A61P 43/00A61P 5/50G01N 2333/474C12N 15/09C12N 15/111G01N 2333/4733A61P 3/04C07K 14/4733C07K 14/474C12Q 1/6811C12Q 1/6897C12Q 1/6813C12N 15/11C12N 15/63
49
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A reporter construct contains mammalian INGAP 5′-regulatory region or a fragment thereof, a minimal promoter element from mammalian INGAP or a heterologous promoter, and a reporter gene. The reporter construct can be used to screen for agents which alone or in combination up-regulate or down-regulate reporter gene expression. Alternatively, the reporter construct can be used to screen for agents that bind to the hamster INGAP 5′-regulatory region or a fragment thereof.
Claims
exact text as granted — not AI-modifiedWe claim:
1 . A method for identifying agents which modulate INGAP expression comprising:
contacting a host cell comprising a reporter construct having at least one INGAP regulatory region selected from nucleotides from the group consisting of SEQ ID NO: 1, 2, 23, 32, 35, 37, 28, 24, 25, 26, 27, 29, 30, 31, 33, 34, 38, and 36 and a region encoding a detectable product with a test agent; determining expression of the detectable product in the cell; and identifying the test agent as a modulator of INGAP expression if the test agent modulates expression of the detectable product in the cell.
2 . The method of claim 5 wherein the regulatory sequence comprises nucleotides 1-3137 of SEQ ID NO: 2.
3 . The method of claim 1 wherein the reporter construct further comprises: a promoter element interposed between the regulatory region nucleotide sequence and the nucleotide sequence encoding the detectable product.
4 . The method of claim 3 wherein the promoter element is selected from SEQ ID NO: 2.
5 . An in vitro method for identifying agents which modulate INGAP expression, comprising: a. contacting a reporter construct having at least one INGAP regulatory region and a nucleotide sequence encoding a detectable product with a test substance under conditions sufficient for transcription and translation of said nucleotide sequence; determining expression of the detectable protein or nucleic acid product; and identifying the test substance as a modulator of INGAP expression if the test substance modulates expression of the detectable product.
6 . The method of claim 5 wherein the regulatory region nucleotide sequence comprises of one or more regions chosen from nucleotides from the group consisting of SEQ ID NO: 1, -2, 23, 32, 35, 37, 28, 24, 25, 26, 27, 29, 30, 31, 33, 34, 38, and 36.
7 . The method of claim 6 wherein the regulatory sequence comprises nucleotides 1-3137 of SEQ ID NO: 2.
8 . The method of claim 5 wherein the reporter construct further comprises: a promoter element interposed between the regulatory region nucleotide sequence and the nucleotide sequence encoding the detectable product.
9 . The method of claim 8 wherein the promoter element is selected from SEQ ID NO: 2.
10 . A method for inducing INGAP expression in a mammal in need thereof, comprising administering to the mammal an effective amount of a factor that stimulates INGAP expression in the said mammal.
11 . The method of claim 10 wherein the factor that stimulates INGAP expression was identified by:
contacting a host cell comprising a reporter construct having at least one INGAP regulatory region and a region encoding a detectable product with a test agent;
determining expression of the detectable product in the cell; and
identifying the test agent as a modulator of INGAP expression if the test agent modulates expression of the detectable product in the cell; wherein the regulatory region nucleotide sequence comprises of one or more regions chosen from nucleotides from the group consisting of SEQ ID NO: 1, -2, 23, 32, 35, 37, 28, 24, 25, 26, 27, 29, 30, 31, 33, 34, 38, and 36.
12 . The method of claim 11 wherein the factor that stimulates INGAP expression was identified by:
contacting the SEQ ID NOS: 1, -2, 23, 32, 35, 37, 28, 24, 25, 26, 27, 29, 30, 31, 33, 34, 38, and 36 or fragments thereof with a test agent;
determining binding of the test agent to the nucleic acid; and
identifying the test agent as a potential modulator of INGAP expression if the test agent binds to the nucleic acid
15 . The method of claim 10 wherein the factor that stimulates INGAP expression is selected from hLIF or PMA.Join the waitlist — get patent alerts
Track US2012058078A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.